Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis. [electronic resource]
Producer: 20051019Description: 61-8 p. digitalISSN:- 0022-510X
- Age Factors
- Amyotrophic Lateral Sclerosis -- drug therapy
- Animals
- Blotting, Western -- methods
- Cell Count -- methods
- Disability Evaluation
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Immunohistochemistry -- methods
- Injections, Spinal -- methods
- Insulin-Like Growth Factor I -- therapeutic use
- Mice
- Mice, Transgenic
- Motor Neurons -- drug effects
- Protein Serine-Threonine Kinases -- metabolism
- Proto-Oncogene Proteins -- metabolism
- Proto-Oncogene Proteins c-akt
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- Superoxide Dismutase -- genetics
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.